vTv Therapeutics (VTVT) Interest Coverage Ratio (2016 - 2025)
Historic Interest Coverage Ratio for vTv Therapeutics (VTVT) over the last 11 years, with Q3 2025 value amounting to 2139.8.
- vTv Therapeutics' Interest Coverage Ratio changed N/A to 2139.8 in Q3 2025 from the same period last year, while for Sep 2025 it was 5963.0, marking a year-over-year decrease of 7395.71%. This contributed to the annual value of 1961.69 for FY2023, which is 3054.74% down from last year.
- According to the latest figures from Q3 2025, vTv Therapeutics' Interest Coverage Ratio is 2139.8.
- In the past 5 years, vTv Therapeutics' Interest Coverage Ratio ranged from a high of 267.17 in Q3 2021 and a low of 6481.0 during Q1 2022
- For the 4-year period, vTv Therapeutics' Interest Coverage Ratio averaged around 2058.02, with its median value being 1342.0 (2023).
- Per our database at Business Quant, vTv Therapeutics' Interest Coverage Ratio tumbled by 687871.58% in 2021 and then soared by 4290.22% in 2022.
- Over the past 4 years, vTv Therapeutics' Interest Coverage Ratio (Quarter) stood at 1851.5 in 2021, then skyrocketed by 42.9% to 1057.17 in 2022, then surged by 36.39% to 672.43 in 2023, then crashed by 218.22% to 2139.8 in 2025.
- Its last three reported values are 2139.8 in Q3 2025, 672.43 for Q4 2023, and 1342.0 during Q3 2023.